Stay updated with breaking news from 86887310. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Surmodics (NASDAQ:SRDX – Free Report) had its price objective lowered by Needham & Company LLC from $47.00 to $43.00 in a report released on Wednesday morning, Benzinga reports. The brokerage currently has a buy rating on the stock. Separately, StockNews.com downgraded Surmodics from a strong-buy rating to a buy rating in a report on Wednesday, […]
StockNews.com upgraded shares of Surmodics (NASDAQ:SRDX – Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Tuesday. Separately, Needham & Company LLC reissued a buy rating and set a $47.00 target price on shares of Surmodics in a research report on Wednesday, April 10th. View Our […]
Surmodics (NASDAQ:SRDX – Get Free Report) and Shockwave Medical (NASDAQ:SWAV – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, earnings, risk and analyst recommendations. Risk and Volatility Surmodics has a beta of 1.05, […]
Surmodics (NASDAQ:SRDX – Get Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share guidance of -1.170–0.870 for the period, compared to the consensus earnings per share estimate of -1.160. The company issued revenue guidance of $113.0 million-$117.0 million, compared to the consensus revenue estimate […]
Surmodics (NASDAQ:SRDX – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share guidance of -1.170–0.870 for the period, compared to the consensus earnings per share estimate of -1.160. The company issued revenue guidance of $113.0 million-$117.0 million, compared to the consensus revenue estimate of $119.3 million. Analyst […]